Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways . (2023). Biomolecules and Biomedicine, 23(3), 457–470. https://doi.org/10.17305/bb.2022.8549